Question

Difficulty: EasyEnd-of-Life and Palliative Care

Match the following common end-of-life clinical scenarios or symptoms with their most appropriate initial palliative intervention.

  • Refractory dyspnea in a patient with end-stage chronic obstructive pulmonary diseaseLow-dose oral or intravenous morphine
  • Excessive, audible terminal respiratory secretions ('death rattle') in a comatose patientSublingual atropine or subcutaneous glycopyrrolate
  • Severe, hyperactive terminal delirium with distressing agitationIntravenous or subcutaneous haloperidol
  • Focal, severe, well-localized pain from a known vertebral metastasisPalliative radiation therapy

Answer

Dyspnea matches with low-dose morphine; terminal secretions match with atropine/glycopyrrolate; terminal delirium matches with haloperidol; and focal bone pain matches with palliative radiation therapy.
Each symptom in end-of-life care has a specific targeted therapy. Dyspnea is treated centrally with opioids to reduce air hunger. Secretions are managed by drying agents (anticholinergics). Hyperactive delirium is treated with antipsychotics. Localized bone pain is effectively targeted with localized palliative radiation.

Step-by-Step Solution

1
Analyze each clinical scenario to identify the primary distressing symptom.
The primary symptoms are dyspnea, terminal secretions, hyperactive delirium, and focal bone pain.
Accurate symptom identification is required to select the targeted palliative intervention.
2
Select the most appropriate, evidence-based intervention for each identified symptom.
Morphine is selected for dyspnea, anticholinergics for secretions, haloperidol for delirium, and radiation for localized bone metastases.
These represent the standard of care in palliative medicine for maximizing patient comfort.

Key Concept

First-line pharmacologic and procedural interventions for common end-of-life symptoms.
Estimated Time:1m 0s
Rate this question